Hexaminolevulinate
- Hexaminolevulinate
- Hexyl 5-amino-4-oxopentanoate
- 140898-97-1
- 5-Aminolevulinic acid hexyl ester
- Hexyl 5-aminolevulinate
- Create:2006-04-28
- Modify:2025-01-25
- (14C)-hexaminolevulinate
- 5-ALAHE
- 5-aminolevulinic acid hexyl ester
- ALA hexyl ester
- aminolevulinic acid hexylester
- hexa ALA
- hexaminolevulinate
- hexaminolevulinate hydrochloride
- hexyl-aminolevulinate
- hexylaminolevulinate
- Hexaminolevulinate
- Hexyl 5-amino-4-oxopentanoate
- 140898-97-1
- 5-Aminolevulinic acid hexyl ester
- Hexyl 5-aminolevulinate
- Aminolevulinic acid hexyl ester
- UNII-G7H20TKI67
- Pentanoic acid, 5-amino-4-oxo-, hexyl ester
- G7H20TKI67
- 5-Amino-4-oxopentanoic acid hexyl ester
- DTXSID40161487
- 4-Hexyloxycarbonyl-2-oxobutylammoniumchloride
- (14C)-hexaminolevulinate
- HexvixR
- Hexaminolevulinato
- starbld0000848
- HEXAMINOLEVULINATE [MI]
- SCHEMBL1070663
- CHEMBL1201784
- DTXCID9083978
- 5-aminolevulinic acid hexyl-ester
- HEXAMINOLEVULINATE [VANDF]
- CHEBI:134892
- RYQOILLJDKPETL-UHFFFAOYSA-N
- HEXAMINOLEVULINATE [WHO-DD]
- DB06261
- DB-187533
- Hexyl(5-amino-4-oxopentanoat)-hydrochlorid
- HY-157943
- CS-1009782
- NS00003888
- EN300-7513846
- BRD-K73753850-003-01-6
- Q27095709
◉ Summary of Use during Lactation
No information is available on the clinical use of hexaminolevulinate during breastfeeding. After instillation into the bladder, only about 7% of a dose is absorbed into the maternal bloodstream, so the amount of drug excreted into milk is expected to be minimal. Until more data become available, hexaminolevulinate should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.
◉ Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
◉ Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=RYQOILLJDKPETL-UHFFFAOYSA-N
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/Hexyl 5-aminolevulinatehttps://commonchemistry.cas.org/detail?cas_rn=140898-97-1
- ChemIDplusChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_useHexaminolevulinatehttps://www.drugbank.ca/drugs/DB06261
- EPA DSSToxHexyl 5-aminolevulinatehttps://comptox.epa.gov/dashboard/DTXSID40161487CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingHEXAMINOLEVULINATEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/G7H20TKI67
- ChEBI5-aminolevulinic acid hexyl esterhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:134892
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licenceHEXAMINOLEVULINATEhttps://platform.opentargets.org/drug/CHEMBL1201784
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jsp5-aminolevulinic acid hexyl esterhttps://ctdbase.org/detail.go?type=chem&acc=C419924
- European Medicines Agency (EMA)LICENSEInformation on the European Medicines Agency's (EMA) website is subject to a disclaimer and copyright and limited reproduction notices.https://www.ema.europa.eu/en/about-us/legal-noticehexaminolevulinate (P/0070/2013)https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001245-pip01-11
- Drugs and Lactation Database (LactMed)Hexaminolevulinatehttps://www.ncbi.nlm.nih.gov/books/n/lactmed/LM1373/
- EU Clinical Trials Register
- Human Metabolome Database (HMDB)LICENSEHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.http://www.hmdb.ca/citingHexaminolevulinatehttp://www.hmdb.ca/metabolites/HMDB0253144
- Japan Chemical Substance Dictionary (Nikkaji)
- Metabolomics Workbench
- NIPH Clinical Trials Search of Japan
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmlhexyl 5-aminolevulinatehttps://rxnav.nlm.nih.gov/id/rxnorm/1426872
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/HexaminolevulinateNORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- Springer Nature
- WHO Anatomical Therapeutic Chemical (ATC) ClassificationLICENSEUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.https://www.whocc.no/copyright_disclaimer/Hexaminolevulinatehttps://www.whocc.no/atc_ddd_index/?code=V04CX06
- Wikidatahexaminolevulinatehttps://www.wikidata.org/wiki/Q5749089
- PubChem
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.html5-aminolevulinic acid hexyl esterhttps://www.ncbi.nlm.nih.gov/mesh/67419924
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 404072621https://pubchem.ncbi.nlm.nih.gov/substance/404072621
- NCBI